Table 1. Patient, treatment, and tumor characteristics.
| Patient Characteristic | All patients (n=40) | |
|---|---|---|
| Median age, years (range) | 60 (33-82) | |
| Gender | ||
| Male | 23 (57.5%) | |
| Female | 17 (42.5%) | |
| ECOG | ||
| 0 | 28 (70%) | |
| >0 | 12 (30%) | |
| Surgery | 19 (47.5%) | |
| anti-EGFR antibody | 16 (40%) | |
| anti-VEGF | 20 (50%) | |
| HAI Pump | 24 (60%) | |
| Tumor Volume cm3 (range) | 281 (6-1790) | |
| Largest lesion cm (range) | 4.9 (1.6-15) | |
| Number of lesions | ||
| ≤ 3 | 18 (45%) | |
| > 3 | 22 (55%) | |
| CEA (range) | 1032 (3-23938) | |
| Glass beads | 15 (37.5%) | |
| Stasis | 9 (22.5%) | |
| Pathway | Mutation | |
| WT | WT | 16 (40%) |
| MAPK | KRAS | 14 (35%) |
| NRAS | 2 (5%) | |
| BRAF | 2 (5%) | |
| MEK1 | 0 (0%) | |
| PI3K | PIK3CA | 9 (22.5%) |
| AKT1 | 1 (2.5%) | |
Abbreviations: WT=wild type, ECOG=Eastern Cooperative Oncology Group Performance Status, HAI=Hepatic arterial infusion pump, CEA=carcinoembryonic antigen.